Schedule of Components of Net Deferred Tax Assets and Liabilities (Details) - USD ($) $ in Thousands	Dec. 31, 2021	Dec. 31, 2020
Income Tax Disclosure [Abstract]
Net operating losses	$ 15,988	$ 9,742
Research and Development costs	7,077
Amortization & depreciation	1,108	150
R&D credits	82
Other	54
Stock compensation	708	271
Total deferred tax assets	25,016	10,163
Research and development costs		(94)
Deferred tax assets, net	25,016	10,069
Less: Valuation allowance	(23,711)	(9,437)
Deferred tax assets, net	$ 1,305	$ 632